Omega Diagnostics Group PLC
11 March 2008
Omega Diagnostics Group PLC
('Omega' or 'the Company')
Directors Shareholdings
Omega Diagnostics Group PLC announces that on 11 March 2008 Andrew Shepherd,
Chief Executive of the Company, purchased 16,129 Ordinary Shares of 4p each ('
Ordinary Shares') in the Company at a price of 31p each, taking his total
holding to 918,697 Ordinary Shares, representing 6.18% of the total issued share
capital of the Company.
Further to RNS No. 2672P issued on 4 March the Company confirms that the
purchase price of the shares bought by David Evans, Non-Executive Chairman was
28p. On 4 March Omega announced that David Evans bought 10,000 Ordinary Shares
taking his holding to 110,000 Ordinary Shares, representing 0.74% of the total
issued share capital of the Company.
ENDS
Contacts:
Omega Diagnostics Group PLC Andrew Shepherd, Chief Executive
Tel: 01259 763030 Kieron Harbinson, Finance Director
www.omegadiagnostics.com
Landsbanki Securities (UK) Limited Thilo Hoffmann, Corporate Finance
Nominated Adviser & Broker Simon Brown, Corporate Finance
Tel: 020 7426 9000
Parkgreen Communications Limited
T: 020 7479 7933 Paul McManus
Mob: 07980 541 893 paul.mcmanus@parkgreenmedia.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.